Starsource Multitrade

Starsource Multitrade EV/EBITDA

The EV/EBITDA (Enterprise Value to EBITDA) of Starsource Multitrade (506365.BO) as of Oct 21, 2026 is -3,146.27. In the previous year, EV/EBITDA (Enterprise Value to EBITDA) was -54.56 — a change of 5,666.50% (lower).

EV/EBITDA

-3,146.27

YoY

5,666.50%

Last updated:

EV/EBITDA (Enterprise Value to EBITDA) of Starsource Multitrade is 2026 -3,146.27 . EV/EBITDA (Enterprise Value to EBITDA) of Starsource Multitrade was 2025 -54.56 . It decreases by 5,666.50% lower compared to the previous year.

The Starsource Multitrade EV/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBITDA
Date
EV/EBITDA
Jan 1, 2019
-29.91 INR
Jan 1, 2020
-36.49 INR
Jan 1, 2021
-105.59 INR
Jan 1, 2022
-40.05 INR
Jan 1, 2023
-52.26 INR
Jan 1, 2024
-58.30 INR
Jan 1, 2025
-54.56 INR
Jan 1, 2026
-3,146.27 INR
The Starsource Multitrade EV/EBITDA history
YEAREV/EBITDAYoY
-3,146.27+5,666.50%
-54.56-6.42%
-58.30+11.55%
-52.26+30.51%
-40.05-62.07%
-105.59+189.40%
-36.49+21.98%
-29.91-43.53%
-52.97-34.92%
-81.38-252.79%
53.26+27.15%
41.89-22.68%
54.18—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Starsource Multitrade Stock analysis

What does Starsource Multitrade do? Starsource Multitrade Ltd focuses on acquiring power and chemicals businesses, having transitioned from its former role as a pharmaceutical company. The company is exploring new business opportunities in the power and chemicals sectors, aiming to expand its portfolio through strategic acquisitions. Chemo Pharma Laboratories Ltd, which was formerly a pharmaceutical company, is now part of this strategic shift, though it has no current operations. The firm targets opportunities in power and chemicals to build its business model. The company's primary revenue stream comes from acquiring and developing power and chemicals businesses, with Chemo Pharma Laboratories Ltd serving as a former entity that has shifted focus. It does not currently operate any pharmaceutical business, instead concentrating on power and chemicals acquisitions. The business model relies on identifying and integrating new acquisitions in the power and chemicals sectors to generate revenue. Starsource Multitrade Ltd is actively seeking to acquire businesses in the power and chemicals sectors, having moved away from its pharmaceutical roots. The firm has no current operations, indicating a focus on future acquisitions rather than existing business activities. Chemo Pharma Laboratories Ltd, once a pharmaceutical company, is now part of the company's strategic repositioning towards power and chemicals. Starsource Multitrade is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Starsource Multitrade stock

EV/EBITDA (Enterprise Value to EBITDA) of Starsource Multitrade is -3,146.27 in 2026.

EV/EBITDA (Enterprise Value to EBITDA) of Starsource Multitrade changed from -54.56 to -3,146.27, representing a 5,666.50% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/EBITDA (Enterprise Value to EBITDA) Starsource Multitrade since 2006 – with annual values, charts, and detailed analysis.

The EV/EBITDA ratio is a widely used valuation metric that compares a company's enterprise value to its EBITDA. It normalizes for differences in capital structure, taxation, and depreciation policies.

To evaluate EV/EBITDA (Enterprise Value to EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBITDA (Enterprise Value to EBITDA).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBITDA (Enterprise Value to EBITDA)'s Starsource Multitrade with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Starsource Multitrade

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Starsource Multitrade